Metformin Does Not Improve Survival in High-Risk Breast Cancer

MONDAY, June 6, 2022 -- For patients with high-risk nonmetastatic breast cancer receiving standard therapy, the addition of metformin does not improve invasive disease-free survival, according to a study published in the May 24/31 issue of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news